| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniosynostoses | 43 | 2023 | 401 | 8.880 |
Why?
|
| Cranial Sutures | 14 | 2023 | 93 | 3.170 |
Why?
|
| Skull | 16 | 2023 | 813 | 3.090 |
Why?
|
| Arnold-Chiari Malformation | 14 | 2023 | 154 | 2.720 |
Why?
|
| Endoscopy | 19 | 2021 | 1785 | 2.370 |
Why?
|
| Spinal Fusion | 19 | 2023 | 1241 | 1.710 |
Why?
|
| Head Protective Devices | 7 | 2019 | 114 | 1.570 |
Why?
|
| Cervical Vertebrae | 16 | 2023 | 975 | 1.560 |
Why?
|
| Craniotomy | 16 | 2022 | 729 | 1.540 |
Why?
|
| Neural Tube Defects | 8 | 2023 | 256 | 1.280 |
Why?
|
| Neurosurgery | 3 | 2023 | 643 | 1.220 |
Why?
|
| Frontal Bone | 11 | 2019 | 105 | 1.210 |
Why?
|
| Neurosurgical Procedures | 15 | 2022 | 2002 | 1.180 |
Why?
|
| Spinal Diseases | 8 | 2023 | 538 | 1.130 |
Why?
|
| Dermoid Cyst | 4 | 2022 | 93 | 1.070 |
Why?
|
| Athletic Injuries | 9 | 2021 | 1154 | 1.020 |
Why?
|
| Spinal Injuries | 6 | 2021 | 301 | 1.020 |
Why?
|
| Postoperative Care | 6 | 2019 | 1486 | 0.900 |
Why?
|
| Decompression, Surgical | 6 | 2023 | 594 | 0.880 |
Why?
|
| Acrocephalosyndactylia | 4 | 2022 | 89 | 0.870 |
Why?
|
| Cephalometry | 5 | 2019 | 382 | 0.840 |
Why?
|
| Lumbar Vertebrae | 8 | 2019 | 1848 | 0.840 |
Why?
|
| Orthopedic Procedures | 7 | 2019 | 1288 | 0.800 |
Why?
|
| Coma | 2 | 2015 | 475 | 0.790 |
Why?
|
| Syringomyelia | 5 | 2021 | 64 | 0.780 |
Why?
|
| Bone Screws | 6 | 2020 | 520 | 0.770 |
Why?
|
| Sports Medicine | 3 | 2014 | 225 | 0.770 |
Why?
|
| Spinal Cord Injuries | 6 | 2021 | 931 | 0.760 |
Why?
|
| Infant | 67 | 2023 | 35136 | 0.750 |
Why?
|
| Ventriculoperitoneal Shunt | 4 | 2019 | 194 | 0.730 |
Why?
|
| Atlanto-Axial Joint | 5 | 2019 | 61 | 0.710 |
Why?
|
| Joint Instability | 8 | 2019 | 792 | 0.680 |
Why?
|
| Back Pain | 3 | 2013 | 545 | 0.670 |
Why?
|
| Foramen Magnum | 1 | 2018 | 36 | 0.670 |
Why?
|
| Child | 80 | 2023 | 77709 | 0.650 |
Why?
|
| Occipital Bone | 5 | 2016 | 54 | 0.630 |
Why?
|
| Orthotic Devices | 3 | 2016 | 128 | 0.620 |
Why?
|
| Esthetics | 1 | 2019 | 306 | 0.600 |
Why?
|
| Child, Preschool | 59 | 2023 | 41006 | 0.580 |
Why?
|
| Orbit | 6 | 2019 | 426 | 0.570 |
Why?
|
| Bone Cysts, Aneurysmal | 2 | 2019 | 73 | 0.560 |
Why?
|
| Osteoma, Osteoid | 2 | 2023 | 80 | 0.560 |
Why?
|
| Headache Disorders | 1 | 2018 | 130 | 0.560 |
Why?
|
| Decompressive Craniectomy | 2 | 2017 | 72 | 0.520 |
Why?
|
| Odontoid Process | 2 | 2016 | 47 | 0.520 |
Why?
|
| Neck Injuries | 2 | 2011 | 152 | 0.520 |
Why?
|
| Hypernatremia | 1 | 2015 | 82 | 0.500 |
Why?
|
| Head Injuries, Closed | 1 | 2015 | 136 | 0.480 |
Why?
|
| Bone Transplantation | 5 | 2015 | 907 | 0.480 |
Why?
|
| Laminectomy | 2 | 2017 | 234 | 0.470 |
Why?
|
| Treatment Outcome | 47 | 2023 | 63114 | 0.460 |
Why?
|
| Tomography, X-Ray Computed | 29 | 2022 | 20129 | 0.460 |
Why?
|
| Arachnoid | 1 | 2013 | 48 | 0.460 |
Why?
|
| Paralysis | 1 | 2015 | 247 | 0.460 |
Why?
|
| Meningocele | 1 | 2013 | 45 | 0.440 |
Why?
|
| Spinal Cord | 5 | 2023 | 1809 | 0.440 |
Why?
|
| Spinal Neoplasms | 4 | 2023 | 760 | 0.440 |
Why?
|
| Retrospective Studies | 60 | 2023 | 77449 | 0.440 |
Why?
|
| Arachnoid Cysts | 1 | 2013 | 59 | 0.440 |
Why?
|
| Blood Loss, Surgical | 6 | 2020 | 662 | 0.430 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 126 | 0.430 |
Why?
|
| Traction | 3 | 2021 | 106 | 0.420 |
Why?
|
| Blood Transfusion | 8 | 2021 | 1301 | 0.420 |
Why?
|
| Spinal Cord Compression | 3 | 2015 | 235 | 0.420 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2015 | 794 | 0.420 |
Why?
|
| Magnetic Resonance Imaging | 24 | 2023 | 35421 | 0.390 |
Why?
|
| Scoliosis | 4 | 2021 | 725 | 0.390 |
Why?
|
| Hydrocephalus | 2 | 2015 | 748 | 0.390 |
Why?
|
| Sacrum | 1 | 2013 | 288 | 0.390 |
Why?
|
| Diskectomy | 2 | 2010 | 206 | 0.380 |
Why?
|
| Humans | 154 | 2023 | 744343 | 0.380 |
Why?
|
| Equipment Failure | 3 | 2020 | 578 | 0.380 |
Why?
|
| Adolescent | 58 | 2023 | 85781 | 0.380 |
Why?
|
| Reoperation | 12 | 2021 | 4201 | 0.360 |
Why?
|
| Brain Injuries | 4 | 2015 | 2025 | 0.360 |
Why?
|
| Male | 97 | 2023 | 350118 | 0.360 |
Why?
|
| Parietal Bone | 4 | 2014 | 47 | 0.350 |
Why?
|
| Temporal Lobe | 2 | 2015 | 1670 | 0.340 |
Why?
|
| Plagiocephaly, Nonsynostotic | 1 | 2009 | 29 | 0.340 |
Why?
|
| Spondylolysis | 2 | 2008 | 40 | 0.340 |
Why?
|
| Postoperative Complications | 19 | 2023 | 15295 | 0.330 |
Why?
|
| Spinal Curvatures | 1 | 2009 | 66 | 0.320 |
Why?
|
| Constipation | 2 | 2013 | 546 | 0.320 |
Why?
|
| Follow-Up Studies | 25 | 2019 | 39050 | 0.320 |
Why?
|
| Thoracic Vertebrae | 2 | 2012 | 608 | 0.320 |
Why?
|
| Craniocerebral Trauma | 3 | 2015 | 482 | 0.320 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2008 | 36 | 0.310 |
Why?
|
| Female | 93 | 2023 | 380194 | 0.310 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2011 | 281 | 0.300 |
Why?
|
| Down Syndrome | 2 | 2019 | 880 | 0.300 |
Why?
|
| Spina Bifida Occulta | 2 | 2013 | 31 | 0.300 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2020 | 1018 | 0.300 |
Why?
|
| Seizures | 3 | 2015 | 2859 | 0.290 |
Why?
|
| Length of Stay | 9 | 2021 | 6309 | 0.290 |
Why?
|
| Neurocytoma | 2 | 2016 | 30 | 0.270 |
Why?
|
| Cellvibrio | 1 | 2005 | 5 | 0.260 |
Why?
|
| Hospitals, Pediatric | 5 | 2019 | 1775 | 0.260 |
Why?
|
| Internal Fixators | 2 | 2020 | 188 | 0.260 |
Why?
|
| Etoposide | 3 | 1995 | 641 | 0.260 |
Why?
|
| Glycoside Hydrolases | 1 | 2005 | 133 | 0.250 |
Why?
|
| Critical Care | 6 | 2021 | 2647 | 0.250 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2266 | 0.250 |
Why?
|
| Boston | 9 | 2019 | 9313 | 0.250 |
Why?
|
| Tranexamic Acid | 2 | 2020 | 146 | 0.250 |
Why?
|
| Microsurgery | 1 | 2010 | 796 | 0.240 |
Why?
|
| Astrocytoma | 1 | 2009 | 790 | 0.240 |
Why?
|
| Antifibrinolytic Agents | 2 | 2020 | 254 | 0.230 |
Why?
|
| Spinal Fractures | 3 | 2018 | 696 | 0.230 |
Why?
|
| Quality Improvement | 2 | 2016 | 3749 | 0.230 |
Why?
|
| Vein of Galen Malformations | 1 | 2023 | 53 | 0.220 |
Why?
|
| Skull Base | 2 | 2023 | 306 | 0.220 |
Why?
|
| Nose Neoplasms | 3 | 2016 | 246 | 0.220 |
Why?
|
| Sleep Apnea, Central | 2 | 2013 | 84 | 0.210 |
Why?
|
| Spinal Cord Diseases | 1 | 2005 | 298 | 0.210 |
Why?
|
| Glucosyltransferases | 3 | 2007 | 98 | 0.210 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2023 | 108 | 0.210 |
Why?
|
| Surgical Wound Infection | 3 | 2022 | 1540 | 0.210 |
Why?
|
| Intraoperative Complications | 4 | 2020 | 1198 | 0.200 |
Why?
|
| Hypohidrosis | 1 | 2021 | 29 | 0.200 |
Why?
|
| Flushing | 1 | 2021 | 49 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2023 | 247 | 0.200 |
Why?
|
| Trauma Severity Indices | 2 | 2015 | 481 | 0.200 |
Why?
|
| Brain Concussion | 4 | 2016 | 1320 | 0.200 |
Why?
|
| Neurologic Examination | 2 | 2017 | 930 | 0.190 |
Why?
|
| Meningomyelocele | 3 | 2012 | 165 | 0.190 |
Why?
|
| Paresis | 1 | 2021 | 179 | 0.180 |
Why?
|
| Facial Asymmetry | 2 | 2019 | 171 | 0.180 |
Why?
|
| Apnea | 1 | 2021 | 195 | 0.180 |
Why?
|
| Urodynamics | 2 | 2009 | 347 | 0.180 |
Why?
|
| Time Factors | 13 | 2020 | 40075 | 0.180 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2019 | 63 | 0.170 |
Why?
|
| Spinal Dysraphism | 1 | 2001 | 161 | 0.170 |
Why?
|
| Developmental Disabilities | 2 | 2019 | 1456 | 0.170 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2021 | 257 | 0.170 |
Why?
|
| Neuroendoscopy | 1 | 2019 | 105 | 0.160 |
Why?
|
| Tissue and Organ Harvesting | 3 | 2011 | 369 | 0.160 |
Why?
|
| Cysts | 1 | 2023 | 678 | 0.160 |
Why?
|
| Dura Mater | 3 | 2023 | 291 | 0.160 |
Why?
|
| Cerebral Veins | 3 | 2013 | 156 | 0.150 |
Why?
|
| Cohort Studies | 13 | 2022 | 40561 | 0.150 |
Why?
|
| Pediatrics | 2 | 2018 | 3475 | 0.150 |
Why?
|
| Spondylolisthesis | 1 | 2019 | 163 | 0.150 |
Why?
|
| School Nursing | 1 | 2016 | 31 | 0.140 |
Why?
|
| Age Factors | 8 | 2021 | 18370 | 0.140 |
Why?
|
| Cerebellum | 1 | 2004 | 1488 | 0.140 |
Why?
|
| Neurofibromatosis 1 | 3 | 2013 | 569 | 0.140 |
Why?
|
| Nervous System | 1 | 2000 | 554 | 0.140 |
Why?
|
| Urinary Tract | 1 | 2000 | 309 | 0.140 |
Why?
|
| Football | 1 | 2021 | 460 | 0.140 |
Why?
|
| Serotonin Antagonists | 1 | 2016 | 144 | 0.130 |
Why?
|
| Young Adult | 20 | 2023 | 56430 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2020 | 4042 | 0.130 |
Why?
|
| Ondansetron | 1 | 2016 | 90 | 0.130 |
Why?
|
| Intracranial Hypotension | 1 | 2015 | 41 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 972 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.130 |
Why?
|
| Postoperative Period | 2 | 2019 | 1842 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 1995 | 648 | 0.130 |
Why?
|
| Recurrence | 4 | 2015 | 8340 | 0.130 |
Why?
|
| Skull Fractures | 1 | 2016 | 195 | 0.120 |
Why?
|
| Organophosphorus Compounds | 1 | 1995 | 215 | 0.120 |
Why?
|
| Diabetes Insipidus | 1 | 2015 | 151 | 0.120 |
Why?
|
| Thrombelastography | 1 | 2016 | 164 | 0.120 |
Why?
|
| Brain Neoplasms | 6 | 2016 | 8863 | 0.120 |
Why?
|
| Benchmarking | 1 | 2021 | 1042 | 0.120 |
Why?
|
| Limbic System | 1 | 1997 | 426 | 0.120 |
Why?
|
| Antiemetics | 1 | 2016 | 177 | 0.120 |
Why?
|
| Neck Pain | 1 | 2015 | 180 | 0.120 |
Why?
|
| Braces | 2 | 2015 | 135 | 0.120 |
Why?
|
| Prodrugs | 1 | 1995 | 268 | 0.120 |
Why?
|
| Myelography | 1 | 2013 | 69 | 0.110 |
Why?
|
| Tarlov Cysts | 1 | 2013 | 13 | 0.110 |
Why?
|
| Immobilization | 2 | 2015 | 236 | 0.110 |
Why?
|
| Radiculopathy | 1 | 2016 | 197 | 0.110 |
Why?
|
| Fibrinogen | 1 | 2016 | 894 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 7279 | 0.110 |
Why?
|
| Observer Variation | 1 | 2019 | 2593 | 0.110 |
Why?
|
| Radionuclide Imaging | 2 | 2023 | 2031 | 0.110 |
Why?
|
| Infant, Newborn | 11 | 2016 | 25625 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2008 | 736 | 0.100 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 441 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 1 | 2013 | 160 | 0.100 |
Why?
|
| Bone Diseases, Developmental | 1 | 2013 | 130 | 0.100 |
Why?
|
| Spinal Stenosis | 1 | 2015 | 255 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 981 | 0.100 |
Why?
|
| Rupture | 1 | 2013 | 433 | 0.100 |
Why?
|
| Moyamoya Disease | 2 | 2007 | 238 | 0.100 |
Why?
|
| Cauda Equina | 1 | 2011 | 42 | 0.100 |
Why?
|
| Bone Wires | 1 | 2012 | 122 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12959 | 0.100 |
Why?
|
| RNA-Binding Proteins | 5 | 2000 | 1903 | 0.100 |
Why?
|
| Carboplatin | 1 | 1994 | 801 | 0.100 |
Why?
|
| Radiography | 4 | 2019 | 7023 | 0.100 |
Why?
|
| Synostosis | 2 | 2009 | 43 | 0.100 |
Why?
|
| Brain Stem | 1 | 2016 | 846 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2023 | 2529 | 0.100 |
Why?
|
| Osteomyelitis | 1 | 2015 | 402 | 0.100 |
Why?
|
| Treatment Failure | 3 | 2018 | 2618 | 0.100 |
Why?
|
| Risk Assessment | 7 | 2019 | 23338 | 0.100 |
Why?
|
| Osteopetrosis | 1 | 2010 | 43 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1995 | 624 | 0.090 |
Why?
|
| Skin Temperature | 1 | 2011 | 93 | 0.090 |
Why?
|
| Health Education | 1 | 2017 | 1056 | 0.090 |
Why?
|
| Astigmatism | 2 | 2009 | 69 | 0.090 |
Why?
|
| Steroids | 1 | 2016 | 930 | 0.090 |
Why?
|
| Cervical Atlas | 1 | 2010 | 21 | 0.090 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2013 | 356 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
| Pseudarthrosis | 1 | 2010 | 59 | 0.090 |
Why?
|
| Risk Factors | 14 | 2022 | 72290 | 0.090 |
Why?
|
| Reflex, Abnormal | 1 | 2010 | 84 | 0.090 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2013 | 349 | 0.090 |
Why?
|
| Amblyopia | 2 | 2013 | 143 | 0.090 |
Why?
|
| Intraoperative Care | 3 | 2020 | 767 | 0.090 |
Why?
|
| Administration, Oral | 3 | 2013 | 3913 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage, Traumatic | 1 | 2009 | 12 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2019 | 2531 | 0.090 |
Why?
|
| Dyskinesias | 1 | 2010 | 78 | 0.090 |
Why?
|
| Osteogenesis, Distraction | 1 | 2012 | 219 | 0.090 |
Why?
|
| Students | 2 | 2016 | 1654 | 0.090 |
Why?
|
| Premedication | 1 | 2010 | 258 | 0.080 |
Why?
|
| Tissue Expansion | 1 | 2010 | 162 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 1671 | 0.080 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2011 | 214 | 0.080 |
Why?
|
| Clostridium cellulolyticum | 1 | 2008 | 2 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2015 | 2290 | 0.080 |
Why?
|
| Cellulase | 1 | 2008 | 10 | 0.080 |
Why?
|
| Anaphylaxis | 1 | 2016 | 746 | 0.080 |
Why?
|
| Urinary Incontinence | 1 | 2013 | 496 | 0.080 |
Why?
|
| Supine Position | 1 | 2009 | 205 | 0.080 |
Why?
|
| Protein Structure, Secondary | 7 | 2008 | 1246 | 0.080 |
Why?
|
| Protein Conformation | 8 | 2008 | 4011 | 0.080 |
Why?
|
| Binding Sites | 9 | 2006 | 6114 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 547 | 0.080 |
Why?
|
| Urination | 1 | 2009 | 204 | 0.080 |
Why?
|
| Catheterization, Peripheral | 1 | 2012 | 345 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2013 | 689 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2010 | 196 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 1997 | 2132 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 8 | 2008 | 3846 | 0.080 |
Why?
|
| Bone Nails | 1 | 2009 | 219 | 0.080 |
Why?
|
| Cellulosomes | 1 | 2007 | 2 | 0.080 |
Why?
|
| Clostridium thermocellum | 1 | 2007 | 2 | 0.080 |
Why?
|
| Lectins | 2 | 2000 | 513 | 0.080 |
Why?
|
| Skull Neoplasms | 1 | 2008 | 173 | 0.080 |
Why?
|
| Models, Molecular | 8 | 2007 | 5456 | 0.070 |
Why?
|
| Hospitalization | 3 | 2016 | 10262 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8642 | 0.070 |
Why?
|
| Low Back Pain | 1 | 2016 | 956 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2021 | 778 | 0.070 |
Why?
|
| Vasospasm, Intracranial | 1 | 2009 | 208 | 0.070 |
Why?
|
| Ribosomal Proteins | 3 | 1999 | 360 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 7181 | 0.070 |
Why?
|
| Child Welfare | 1 | 2011 | 523 | 0.070 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2007 | 171 | 0.070 |
Why?
|
| Glycosyltransferases | 1 | 2007 | 113 | 0.070 |
Why?
|
| Facial Bones | 1 | 2007 | 201 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2011 | 798 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2023 | 53288 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 3462 | 0.070 |
Why?
|
| Macrolides | 1 | 2007 | 201 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2016 | 3420 | 0.070 |
Why?
|
| Ketolides | 1 | 2005 | 12 | 0.070 |
Why?
|
| Cell Wall | 2 | 2008 | 422 | 0.070 |
Why?
|
| Craniofacial Abnormalities | 1 | 2008 | 315 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3528 | 0.070 |
Why?
|
| Plants | 1 | 2007 | 316 | 0.070 |
Why?
|
| Osteolysis | 1 | 2007 | 270 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2011 | 969 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2002 | 2948 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 271 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2018 | 4558 | 0.060 |
Why?
|
| Adult | 23 | 2023 | 214055 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3843 | 0.060 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 494 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 1475 | 0.060 |
Why?
|
| Gram-Positive Bacteria | 1 | 2005 | 184 | 0.060 |
Why?
|
| Gait | 1 | 2010 | 793 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1855 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2708 | 0.060 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2023 | 39 | 0.060 |
Why?
|
| Methyltransferases | 1 | 2006 | 367 | 0.060 |
Why?
|
| RNA, Double-Stranded | 2 | 1995 | 290 | 0.060 |
Why?
|
| Forehead | 2 | 2014 | 69 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2000 | 507 | 0.060 |
Why?
|
| Drosophila Proteins | 3 | 2000 | 1703 | 0.060 |
Why?
|
| Urochordata | 2 | 2000 | 21 | 0.060 |
Why?
|
| Protein Folding | 4 | 2002 | 843 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2010 | 1171 | 0.060 |
Why?
|
| Surgical Flaps | 1 | 2012 | 1640 | 0.060 |
Why?
|
| Ovarian Neoplasms | 3 | 1995 | 4838 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 761 | 0.060 |
Why?
|
| Thermodynamics | 5 | 2008 | 596 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 1995 | 3396 | 0.060 |
Why?
|
| Activin Receptors, Type II | 1 | 2023 | 127 | 0.060 |
Why?
|
| Bacterial Proteins | 4 | 2007 | 3848 | 0.060 |
Why?
|
| Rhabdoid Tumor | 1 | 2005 | 212 | 0.050 |
Why?
|
| Bradykinin | 1 | 2003 | 214 | 0.050 |
Why?
|
| Biotechnology | 1 | 2005 | 281 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2010 | 1951 | 0.050 |
Why?
|
| Amino Acid Sequence | 12 | 2002 | 13815 | 0.050 |
Why?
|
| Forecasting | 1 | 2012 | 2951 | 0.050 |
Why?
|
| Disease Progression | 3 | 2020 | 13284 | 0.050 |
Why?
|
| Emergency Service, Hospital | 3 | 2016 | 7659 | 0.050 |
Why?
|
| Molecular Sequence Data | 12 | 2006 | 18111 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 5853 | 0.050 |
Why?
|
| Teratoma | 1 | 2005 | 395 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 1392 | 0.050 |
Why?
|
| Nicotine | 1 | 2007 | 681 | 0.050 |
Why?
|
| United States | 6 | 2020 | 69872 | 0.050 |
Why?
|
| Sphenoid Bone | 1 | 2002 | 172 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3507 | 0.050 |
Why?
|
| Neck | 1 | 2005 | 697 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2009 | 1928 | 0.050 |
Why?
|
| Penicillin Resistance | 1 | 2000 | 84 | 0.050 |
Why?
|
| Mutation | 10 | 2023 | 29786 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2000 | 2849 | 0.050 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 506 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1119 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2107 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 498 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 514 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2023 | 349 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1790 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2007 | 1533 | 0.040 |
Why?
|
| North America | 1 | 2023 | 1249 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2000 | 1861 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 1050 | 0.040 |
Why?
|
| E-Selectin | 1 | 2002 | 579 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 570 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2010 | 2925 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2007 | 1180 | 0.040 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 1999 | 36 | 0.040 |
Why?
|
| Crystallography, X-Ray | 5 | 2007 | 2011 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 707 | 0.040 |
Why?
|
| Craniofacial Dysostosis | 2 | 2014 | 73 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2001 | 384 | 0.040 |
Why?
|
| Ligases | 1 | 2000 | 333 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 1995 | 4933 | 0.040 |
Why?
|
| Temperature | 2 | 2019 | 2206 | 0.040 |
Why?
|
| RNA | 2 | 2000 | 2749 | 0.040 |
Why?
|
| Galactose | 1 | 1999 | 306 | 0.040 |
Why?
|
| Sclerotherapy | 1 | 2019 | 175 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1155 | 0.040 |
Why?
|
| Missouri | 1 | 2017 | 117 | 0.040 |
Why?
|
| Ifosfamide | 2 | 1995 | 228 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 6993 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2007 | 1241 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2021 | 9849 | 0.040 |
Why?
|
| Doxycycline | 1 | 2019 | 326 | 0.040 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 1999 | 145 | 0.040 |
Why?
|
| Breast Neoplasms | 5 | 1998 | 20822 | 0.040 |
Why?
|
| Polyribonucleotide Nucleotidyltransferase | 1 | 1997 | 5 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 639 | 0.040 |
Why?
|
| Thiolester Hydrolases | 1 | 1998 | 86 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2021 | 7729 | 0.040 |
Why?
|
| Pain | 3 | 2019 | 4986 | 0.040 |
Why?
|
| Crystallization | 3 | 2007 | 524 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 549 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2019 | 310 | 0.040 |
Why?
|
| Strabismus | 2 | 2013 | 287 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 8949 | 0.040 |
Why?
|
| Bicuculline | 1 | 1997 | 99 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 3251 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 10943 | 0.040 |
Why?
|
| Risk | 2 | 2020 | 9687 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 1997 | 128 | 0.040 |
Why?
|
| Hypotension | 1 | 2003 | 884 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6364 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 255 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 1999 | 414 | 0.040 |
Why?
|
| Myoclonus | 1 | 1997 | 104 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4982 | 0.030 |
Why?
|
| Intradermal Tests | 1 | 2016 | 44 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 2008 | 563 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4328 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2001 | 5021 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2017 | 243 | 0.030 |
Why?
|
| Helminth Proteins | 1 | 1996 | 171 | 0.030 |
Why?
|
| Pneumococcal Infections | 1 | 2000 | 497 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12026 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 547 | 0.030 |
Why?
|
| Insect Hormones | 1 | 1995 | 75 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2011 | 2124 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1996 | 249 | 0.030 |
Why?
|
| Recombinant Proteins | 4 | 2000 | 6622 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1998 | 449 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2007 | 2071 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2000 | 714 | 0.030 |
Why?
|
| Standard of Care | 1 | 2018 | 564 | 0.030 |
Why?
|
| Filgrastim | 1 | 1994 | 133 | 0.030 |
Why?
|
| Prevalence | 2 | 2020 | 15226 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 588 | 0.030 |
Why?
|
| Neoplasm Metastasis | 4 | 2007 | 4851 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
| Wound Healing | 2 | 2018 | 2785 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2023 | 2564 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2017 | 454 | 0.030 |
Why?
|
| Incidence | 4 | 2021 | 20947 | 0.030 |
Why?
|
| Injections, Epidural | 1 | 2016 | 195 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2001 | 2839 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 916 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 681 | 0.030 |
Why?
|
| Spine | 1 | 2001 | 1144 | 0.030 |
Why?
|
| Ear, External | 1 | 2014 | 161 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1996 | 881 | 0.030 |
Why?
|
| Cognition | 1 | 2011 | 6770 | 0.030 |
Why?
|
| Kinetics | 3 | 2008 | 6473 | 0.030 |
Why?
|
| Protein Binding | 5 | 2008 | 9386 | 0.030 |
Why?
|
| Arginine | 1 | 1997 | 944 | 0.030 |
Why?
|
| Buserelin | 1 | 1992 | 17 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1995 | 13695 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2012 | 62 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2012 | 57 | 0.030 |
Why?
|
| Consensus | 1 | 2021 | 2959 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2007 | 3481 | 0.030 |
Why?
|
| Vision, Binocular | 1 | 2013 | 213 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 413 | 0.020 |
Why?
|
| Airway Management | 1 | 2015 | 329 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 1994 | 314 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 1998 | 1149 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1996 | 1159 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2005 | 11524 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 4253 | 0.020 |
Why?
|
| Acute Disease | 1 | 2021 | 7149 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3479 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1994 | 1588 | 0.020 |
Why?
|
| Neurology | 1 | 2018 | 763 | 0.020 |
Why?
|
| Body Weight | 1 | 2021 | 4669 | 0.020 |
Why?
|
| Embolism, Air | 1 | 2010 | 111 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2015 | 890 | 0.020 |
Why?
|
| Laboratories, Hospital | 1 | 2012 | 194 | 0.020 |
Why?
|
| Absenteeism | 1 | 2012 | 250 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1723 | 0.020 |
Why?
|
| Transportation | 1 | 2012 | 214 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 520 | 0.020 |
Why?
|
| Health Care Costs | 2 | 2015 | 3209 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1996 | 852 | 0.020 |
Why?
|
| Smoking | 1 | 2007 | 8987 | 0.020 |
Why?
|
| Ultracentrifugation | 2 | 2000 | 182 | 0.020 |
Why?
|
| Intracranial Aneurysm | 1 | 1999 | 1197 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 1239 | 0.020 |
Why?
|
| Eye Movements | 1 | 2013 | 507 | 0.020 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2009 | 13 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 1999 | 3760 | 0.020 |
Why?
|
| Animals | 13 | 2023 | 168757 | 0.020 |
Why?
|
| Nose | 1 | 2013 | 509 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2014 | 645 | 0.020 |
Why?
|
| Sequence Alignment | 3 | 2000 | 2256 | 0.020 |
Why?
|
| Aftercare | 1 | 1995 | 866 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 15076 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2000 | 2752 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2005 | 9239 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2016 | 2453 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2012 | 497 | 0.020 |
Why?
|
| Pulmonary Circulation | 2 | 2003 | 739 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 1991 | 519 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14722 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 770 | 0.020 |
Why?
|
| Schools | 1 | 2016 | 1433 | 0.020 |
Why?
|
| Protein Denaturation | 2 | 1999 | 237 | 0.020 |
Why?
|
| Neoplasms | 2 | 1999 | 21683 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 1996 | 1419 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2012 | 593 | 0.020 |
Why?
|
| Solutions | 2 | 2000 | 426 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2016 | 2250 | 0.020 |
Why?
|
| Peptide Fragments | 4 | 2002 | 5097 | 0.020 |
Why?
|
| Circle of Willis | 1 | 2007 | 68 | 0.020 |
Why?
|
| Face | 1 | 2013 | 994 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2005 | 1877 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 1416 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 2007 | 87 | 0.020 |
Why?
|
| Lung | 2 | 2003 | 9856 | 0.020 |
Why?
|
| Streptomyces | 1 | 2007 | 89 | 0.020 |
Why?
|
| Phenotype | 3 | 2014 | 16365 | 0.020 |
Why?
|
| Athletes | 1 | 2014 | 1093 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 1999 | 1813 | 0.020 |
Why?
|
| Ilium | 1 | 2007 | 154 | 0.020 |
Why?
|
| Middle Aged | 10 | 2007 | 213383 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9146 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1994 | 1179 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 1776 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2006 | 414 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2007 | 165 | 0.020 |
Why?
|
| Stroke | 1 | 2009 | 9981 | 0.020 |
Why?
|
| Sensation Disorders | 1 | 2007 | 155 | 0.020 |
Why?
|
| Urination Disorders | 1 | 2007 | 241 | 0.020 |
Why?
|
| Oleandomycin | 1 | 2005 | 1 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 1681 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 1413 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3798 | 0.020 |
Why?
|
| Rats | 3 | 1999 | 24260 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2000 | 9648 | 0.020 |
Why?
|
| Critical Illness | 1 | 2018 | 2670 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 8301 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8089 | 0.020 |
Why?
|
| Nasal Bone | 1 | 2005 | 58 | 0.020 |
Why?
|
| Erythromycin | 1 | 2005 | 120 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 876 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15540 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 1991 | 788 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2012 | 985 | 0.020 |
Why?
|
| Drosophila | 3 | 2000 | 1491 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 722 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 711 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2007 | 342 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 626 | 0.020 |
Why?
|
| Lipoma | 1 | 2007 | 334 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2007 | 276 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 2006 | 414 | 0.020 |
Why?
|
| Aged | 6 | 2016 | 163280 | 0.020 |
Why?
|
| Titanium | 1 | 2007 | 494 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1995 | 2948 | 0.020 |
Why?
|
| Electromyography | 1 | 2009 | 1379 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2000 | 1097 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2007 | 13102 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2007 | 413 | 0.010 |
Why?
|
| Bone Plates | 1 | 2007 | 468 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3610 | 0.010 |
Why?
|
| Logistic Models | 2 | 2010 | 13408 | 0.010 |
Why?
|
| Polymers | 1 | 1991 | 1621 | 0.010 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 2003 | 12 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
| Vagotomy | 1 | 2003 | 83 | 0.010 |
Why?
|
| Autopsy | 1 | 2007 | 1020 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2009 | 1172 | 0.010 |
Why?
|
| Base Sequence | 3 | 2002 | 12797 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2007 | 10252 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2010 | 1299 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 4320 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.010 |
Why?
|
| Glycosylation | 1 | 2005 | 1126 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2007 | 1850 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2008 | 1122 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2012 | 1859 | 0.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 312 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 2647 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3679 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 1364 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
| Head | 1 | 2007 | 880 | 0.010 |
Why?
|
| Drug Stability | 1 | 2002 | 291 | 0.010 |
Why?
|
| Trifluoroethanol | 1 | 2000 | 3 | 0.010 |
Why?
|
| Patient Selection | 1 | 2013 | 4215 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1801 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2003 | 621 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2437 | 0.010 |
Why?
|
| Models, Biological | 2 | 2008 | 9583 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 683 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 2000 | 84 | 0.010 |
Why?
|
| Transfection | 2 | 2000 | 5892 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 1995 | 5172 | 0.010 |
Why?
|
| Wisconsin | 1 | 2000 | 124 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 12208 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2007 | 4217 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23403 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 1157 | 0.010 |
Why?
|
| Solubility | 1 | 2002 | 1085 | 0.010 |
Why?
|
| Extravascular Lung Water | 1 | 1999 | 20 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3588 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 668 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2000 | 185 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6538 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2000 | 467 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1994 | 11031 | 0.010 |
Why?
|
| Thermus thermophilus | 1 | 1999 | 19 | 0.010 |
Why?
|
| Calorimetry | 1 | 1999 | 126 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 1770 | 0.010 |
Why?
|
| Ribosomal Protein S6 | 1 | 1999 | 70 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 1035 | 0.010 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2000 | 152 | 0.010 |
Why?
|
| Remission Induction | 1 | 2005 | 2386 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2000 | 290 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 2216 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1999 | 382 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 676 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 81183 | 0.010 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 895 | 0.010 |
Why?
|
| Third Ventricle | 1 | 1999 | 76 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1999 | 264 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2000 | 2255 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1999 | 382 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1999 | 416 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 936 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 588 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 862 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 3616 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 742 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1999 | 854 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1998 | 323 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1999 | 689 | 0.010 |
Why?
|
| Calcium | 2 | 2000 | 5756 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4894 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 3479 | 0.010 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1996 | 100 | 0.010 |
Why?
|
| eIF-2 Kinase | 1 | 1997 | 149 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2002 | 1189 | 0.010 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 1995 | 7 | 0.010 |
Why?
|
| Karyotyping | 1 | 1998 | 1243 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 1997 | 190 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1998 | 585 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25043 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2001 | 1157 | 0.010 |
Why?
|
| Mesna | 1 | 1995 | 66 | 0.010 |
Why?
|
| Epirubicin | 1 | 1995 | 80 | 0.010 |
Why?
|
| Veins | 1 | 1999 | 770 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1999 | 1150 | 0.010 |
Why?
|
| Protons | 1 | 2000 | 1127 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 3912 | 0.010 |
Why?
|
| Half-Life | 1 | 1995 | 661 | 0.010 |
Why?
|
| Physicians | 1 | 2012 | 4567 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 3129 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1997 | 772 | 0.010 |
Why?
|
| Homozygote | 1 | 1998 | 1785 | 0.010 |
Why?
|
| Computer Graphics | 1 | 1995 | 361 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1997 | 912 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1998 | 1179 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 10388 | 0.010 |
Why?
|
| Goserelin | 1 | 1992 | 129 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1992 | 647 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 57776 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3420 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 2916 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4568 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2186 | 0.010 |
Why?
|
| Neutropenia | 1 | 1995 | 895 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 6442 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 4740 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1999 | 4199 | 0.010 |
Why?
|
| Permeability | 1 | 1991 | 738 | 0.010 |
Why?
|
| Disease Management | 1 | 1999 | 2459 | 0.010 |
Why?
|
| Surface Properties | 1 | 1991 | 1184 | 0.000 |
Why?
|
| Oxygen | 1 | 1999 | 4189 | 0.000 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 1992 | 484 | 0.000 |
Why?
|
| DNA | 1 | 2002 | 7301 | 0.000 |
Why?
|
| Kidney | 1 | 2003 | 7186 | 0.000 |
Why?
|
| Blood Pressure | 1 | 2003 | 8554 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1991 | 2505 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1999 | 5985 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1997 | 8436 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17446 | 0.000 |
Why?
|
| Proteins | 1 | 2000 | 6103 | 0.000 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1991 | 957 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 2000 | 4371 | 0.000 |
Why?
|
| Peptides | 1 | 1996 | 4409 | 0.000 |
Why?
|
| Axons | 1 | 1991 | 1684 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 13881 | 0.000 |
Why?
|